BMY
Bristol-Myers Squibb Co
Price:  
50.92 
USD
Volume:  
18,932,526.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Bmy Relative Valuation

110.7%
Upside

As of 2024-03-05, the Relative Valuation of Bristol-Myers Squibb Co (BMY) is 107.28 USD. This relative valuation is based on P/E multiples. With the latest stock price at 50.92 USD, the upside of Bristol-Myers Squibb Co based on Relative Valuation is 110.7%.

The range of the Relative Valuation is 75.16 - 138.98 USD.

Range Selected
Trailing P/E multiples 22.8x - 35.0x 29.1x
Forward P/E multiples 20.9x - 33.1x 27.6x
Fair Price 75.16 - 138.98 107.28
Upside 47.6% - 172.9% 110.7%
50.92 USD
Stock Price
107.28 USD
Fair Price

Bmy Relative Valuation - Historical P/E Data

Date P/E
2024-03-04 12.83
2024-03-01 12.82
2024-02-29 12.79
2024-02-28 12.83
2024-02-27 12.73
2024-02-26 12.73
2024-02-23 13.02
2024-02-22 12.93
2024-02-21 12.83
2024-02-20 12.56
2024-02-16 12.56
2024-02-15 12.46
2024-02-14 12.32
2024-02-13 12.27
2024-02-12 12.54
2024-02-09 12.55
2024-02-08 12.27
2024-02-07 12.26
2024-02-06 12.41
2024-02-05 12.09
2024-02-02 12.27
2024-02-01 12.26
2024-01-31 12.31
2024-01-30 12.45
2024-01-29 12.57
2024-01-26 12.52
2024-01-25 12.50
2024-01-24 12.66
2024-01-23 12.63
2024-01-22 12.49
2024-01-19 12.63
2024-01-18 12.62
2024-01-17 12.59
2024-01-16 12.60
2024-01-12 12.68
2024-01-11 12.65
2024-01-10 12.77
2024-01-09 12.92
2024-01-08 13.05
2024-01-05 13.16
2024-01-04 13.11
2024-01-03 13.18
2024-01-02 13.29
2023-12-29 12.93
2023-12-28 12.91
2023-12-27 12.90
2023-12-26 12.96
2023-12-22 13.18
2023-12-21 12.92
2023-12-20 12.84